News

News2026-03-24T15:57:46+11:00

For all media enquiries please email us on media@melanoma.org.au

A second penicillin moment for cancer treatment

December 14th, 2022|Categories: Research News|Tags: , , |

In a world-first, an early phase trial of an mRNA personalised cancer vaccine has shown promising results for preventing melanoma recurrence in patients with resected high-risk melanoma (stage III and IV).

Comments Off on A second penicillin moment for cancer treatment

MIA shares latest research breakthroughs at world’s largest melanoma conference

October 20th, 2022|Categories: Research News|Tags: , |

Tailoring skin checks based on personal risk, the impact of adjuvant and neo-adjuvant therapies, and the latest in personalised immunotherapy for advanced patients are amongst a plethora of research advances.

Comments Off on MIA shares latest research breakthroughs at world’s largest melanoma conference

Topics

Archives

Go to Top